Victory Capital Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $10.8K | Sell |
|
|||||
|
2024
Q4 | $18.9K | Sell |
|
|||||
|
2024
Q3 | $14.6K | Sell |
|
|||||
|
2024
Q2 | $24.5K | Buy |
|
|||||
|
2024
Q1 | $33.4K | Sell |
|
|||||
|
2023
Q4 | $47.6K | Buy |
|
|||||
|
2023
Q3 | $41.5K | Sell |
|
|||||
|
2023
Q2 | $51.8K | Sell |
|
|||||
|
2023
Q1 | $84.3K | Sell |
|
|||||
|
2022
Q4 | $120K | Sell |
|
|||||
|
2022
Q3 | $145K | Buy |
|
|||||
|
2022
Q2 | $100K | Buy |
|
|||||
|
2022
Q1 | $121K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.56M | Sell |
|
|||||
|
2021
Q2 | $1.76M | Sell |
|
|||||
|
2021
Q1 | $1.94M | Buy |
|
|||||
|
2020
Q4 | $310K | Buy |
|
|||||
|
2020
Q3 | $259K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $330K | Buy |
|
|||||
|
2019
Q4 | $205K | Buy |
|
|||||
|
2019
Q3 | $200K | Buy |
|